Immuron Ltd
corporate_fare Company Profile
Immuron Ltd (NASDAQ:IMRN) is a publicly traded company in the Life Sciences sector. Wiseek monitors IMRN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Immuron Details Strategic Shift to Partner Clinical Assets, Reports Sales Growth
- Immuron Reports 16% Global Sales Growth in Q3, Driven by Strong Canadian Performance
- Immuron Reports Double-Digit Q3 Sales Growth, Driven by Strong Australian and Canadian Performance
- Immuron Establishes Small Holding Share Sale Facility to Reduce Administrative Costs
- Immuron Reports Strong H1 FY26 Results, Strategic Shift to Partner Clinical Assets, and Key Regulatory Milestone
Financial Snapshot
Fiscal year ended June 30, 2025
Revenue
AU$7.29M AUD
Net Income
-AU$5.22M AUD
Diluted EPS
-AU$2.26 AUD
Op. Cash Flow
-AU$6.14M AUD
Gross Profit
AU$4.77M AUD
Operating Income
-AU$5.34M AUD
Cash & Equivalents
AU$2.83M AUD
Debt / Equity
0.00×
Net Margin
-71.6%
Shares Outstanding
233.96M sh
Source: 20-F · filed 2025-09-25 · accession 0001213900-25-091414
Insider Transactions
IMRN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed IMRN - Latest Insights
IMRN
May 07, 2026, 9:40 PM EDT
Price at Filing:
$0.830
Real-time Price:
$1.19
Change:
+$0.360 (+43%)
Market Cap:
$7.827M
IMRN
Apr 17, 2026, 6:00 AM EDT
Price at Filing:
$0.8045
Real-time Price:
$1.19
Change:
+$0.3855 (+48%)
Market Cap:
$7.827M
IMRN
Apr 16, 2026, 9:37 PM EDT
Price at Filing:
$0.8045
Real-time Price:
$1.19
Change:
+$0.3855 (+48%)
Market Cap:
$7.827M
IMRN
Apr 13, 2026, 8:00 AM EDT
Price at Filing:
$0.760
Real-time Price:
$1.19
Change:
+$0.430 (+57%)
Market Cap:
$7.827M
IMRN
Mar 05, 2026, 8:03 AM EST
Price at Filing:
$0.746272
Real-time Price:
$1.19
Change:
+$0.443728 (+59%)
Market Cap:
$7.827M
IMRN
Feb 27, 2026, 9:58 PM EST
Price at Filing:
$0.8494
Real-time Price:
$1.19
Change:
+$0.3406 (+40%)
Market Cap:
$7.827M
IMRN
Feb 17, 2026, 8:00 AM EST
Price at Filing:
$0.730
Real-time Price:
$1.19
Change:
+$0.460 (+63%)
Market Cap:
$7.827M
IMRN
Feb 12, 2026, 8:00 AM EST
Price at Filing:
$0.726
Real-time Price:
$1.19
Change:
+$0.464 (+64%)
Market Cap:
$7.827M
IMRN
Feb 09, 2026, 8:00 AM EST
Price at Filing:
$0.8058
Real-time Price:
$1.19
Change:
+$0.3842 (+48%)
Market Cap:
$7.827M
IMRN
Jan 22, 2026, 9:58 PM EST
Immuron Reports Strong FY25 Sales Growth and Key Clinical Milestones, Outlines Positive FY26 Outlook
Price at Filing:
$0.9706
Real-time Price:
$1.19
Change:
+$0.2194 (+23%)
Market Cap:
$7.827M
IMRN
Jan 20, 2026, 7:01 AM EST
Price at Filing:
$1.11
Real-time Price:
$1.19
Change:
+$0.080 (+7%)
Market Cap:
$7.827M
IMRN
Jan 12, 2026, 8:03 AM EST
Price at Filing:
$0.8848
Real-time Price:
$1.19
Change:
+$0.3052 (+34%)
Market Cap:
$7.827M